Amgen advances toward lupus redemption while gastric cancer candidate struggles Read more →
Novo's CEO 'wishes Pfizer luck' with Metsera drug, but still seeks own monthly GLP-1 Read more →
NHS 'FIT' bowel cancer test reduced unnecessary referrals as cancer numbers remain stable Read more →
« All Events
February 5, 2025 @ 8:30 am
The agenda at BioInfect will focus on the issues surrounding the increasing threat of AMR and how it can be addressed.